Figs. 1A–1C show the analysis results with different databases and tools that the mRNA levels of DLAT were all significantly upregulated in certain tumor tissues, including cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), LIHC, lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC) and stomach adenocarcinoma (STAD). This evidence concerns the gene DLAT and cholangiocarcinoma.